Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data

Moderna shares were flat at $49.81 in premarket trading on Thursday, after the stock jumped 15.8% in the previous session.

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck stock barely budges after five-year Moderna vaccine data keeps Keytruda trade in play

Merck & Co shares held steady on Tuesday following news that the company's personalized cancer vaccine, developed with Moderna, continued to lower the risk of melanoma recurrence and death when used alongside Keytruda. By 2:02 p.m. EST, Merck was down just 0.01% at $108.82, with the stock fluctuating between $107.06 and $109.11.

Stock Market Today 13.01.2026

{“@context”:”https://schema.org”,”@type”:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-13-01-2026/#live”,”headline”:”Stock Market Today 13.01.2026″,”description”:”Live rolling coverage of stock markets, macro data, and major moves.”,”datePublished”:”2026-01-13T00:00:02-05:00″,”dateModified”:”2026-01-13T23:58:31-05:00″,”coverageStartTime”:”2026-01-13T00:00:02-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-13-01-2026/#live/u/58d39bd3a041910c”,”headline”:”WHSP Holdings Insider Buying Reaches AU$3.4 Million, Led by Robert Millner”,”articleBody”:”WHSP Holdings Limited (ASX: SOL) saw insider buying over the past 12 months, led by Robert Millner with an AU$3.4 million purchase at AU$34.48 a share. The current price is about AU$38.00, suggesting purchases near the prevailing level. There were no insider sales in the period. Insiders own 5.4% of the company, worth around AU$782 million at latest prices, a sign of alignment with other shareholders. While such activity isnu0027t the sole predictor of returns, it can
S&P 500 2026 Forecast: 7,490 Target Meets a Data Test as Earnings Season Nears

S&P 500 2026 Forecast: 7,490 Target Meets a Data Test as Earnings Season Nears

Strategists polled by Reuters see the S&P 500 at 7,490 by end-2026, implying gains of just over 9% from end-2025 as investors weigh Fed succession, election risk and the durability of the AI boom. A slim majority—56%—also forecast a market correction in the coming months. “The most under-appreciated tail risk for 2026 is that the Fed eases monetary policy more than economic conditions justify, inadvertently reigniting inflation,” said Lale Akoner, a global market strategist at eToro. Reuters
Dow nears 50,000 as Nvidia CES remarks ignite SanDisk, Micron surge and lift Wall Street

Dow nears 50,000 as Nvidia CES remarks ignite SanDisk, Micron surge and lift Wall Street

U.S. stocks rose on Tuesday, lifting the Dow to a fresh record as chip and healthcare shares led gains. At about 2:30 p.m. ET, the Dow was up 1.02% at 49,476.54, while the S&P 500 gained 0.62% to 6,944.55 and the Nasdaq rose 0.61% to 23,537.96. SanDisk jumped 23% and Moderna climbed 10%; Argent Capital portfolio manager Jed Ellerbroek said he expects “a very strong earnings season for Big Tech” and higher capex, short for capital spending. Reuters

US Stock Market Today Updates

MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

Warsh at Jackson Hole

Policy tone can move rates, USD, equities, gold and crypto simultaneously.

#2

Michigan sentiment

A weak final reading or elevated inflation expectations could pressure risk assets.

#3

Chicago PMI

A surprise versus 58.0 may alter the near-term manufacturing-growth narrative.

View full calendar
Times and estimates may change. Verify before trading.